Real-world assessment of ipi-nivo in anti-PD-(L)-1 refractory Merkel Cell Carcinoma

Real world evaluation of ipilimumab/nivolumab in PD-1/PDL-1 refractory MCC

Event

2nd International Symposium on Merkel Cell Carcinoma, University of Washington School of Medicine

This site represents our opinions only. See our full Disclaimer and Terms of Use Agreement